Locations:
Search
Treatment yields positive results despite late diagnosis and cardiac involvement
Early detection program integrates multiple disciplines to reduce screening barriers and patient anxiety
Newer class of medications evolves care models for patients with hemophilia
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dotatate PET/CT scan and molecular testing informed treatment trajectory
Learn the latest recommendations in diagnosis, treatment and surveillance
A proactive, framework-based approach
Patients on ibrutinib were more than twice as likely to experience atrial fibrillation or heart failure than those on second-generation alternatives.
Expert recommendations introduce use of targeted agents
Combination therapy may soon represent new standard of care
Advertisement
Advertisement